Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03579628
Title AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors (DRIIV-1)
Acronym DRIIV-1
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Onxeo
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL


No variant requirements are available.